Blood News and Research

RSS

‘Testing Millions’ World AIDS Day campaign surpasses its goal by testing more than 4.2M people for HIV

Testing Millions,’ a groundbreaking global effort led by AIDS Healthcare Foundation to test millions of people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more than 4.2 million people for HIV and identifying more than 110,106 HIV-positive individuals in 23 countries around the world.

5 Mar 2010

Combating liver fluke: Queen's University Belfast heads international research effort

Queen's University Belfast is spearheading a £1 million international research effort to combat liver fluke - a parasite which causes disease in livestock, resulting in billions of pounds in losses every year to farmers around the world.

5 Mar 2010

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

St. Baldrick’s Foundation Infusion Center opened for children undergoing chemotherapy treatments

The Children’s Center for Cancer and Blood Diseases of Las Vegas, Nevada’s first and only official nonprofit pediatric cancer center, is proud to announce the opening of an infusion center on March 4. The new St. Baldrick’s Foundation Infusion Center will specialize in intravenous (IV) treatments for children currently undergoing chemotherapy treatments.

5 Mar 2010

South West Liver Unit researchers receive grants for developing Hepatitis C vaccine

Researchers at the South West Liver Unit, based at Plymouth Hospitals NHS Trust and supported by the Peninsula Medical School, are working to save more lives and improve the health of Hepatitis C sufferers around the world by developing a vaccine for the disease.

5 Mar 2010

Risk of MS increases by many folds following infection with EBV: Study

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

5 Mar 2010

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte’s lead regenerative medicine product using Xcellerex’s XDR single use bioreactor system in its FlexFactory®. Humacyte’s product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

Dermatologist addresses common parasitic infestations and latest treatment options at Academy Annual Meeting

If simply the thought of bedbugs, scabies and head lice makes you feel a little itchy, imagine how those affected by these common infestations feel when they learn what has been creeping around them and causing symptoms such as intense itching, red bite marks or irritated scalps.

5 Mar 2010

FDA approves CSL Behring's Hizentra for PI

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.

4 Mar 2010

Scientists discover genetic cause of Quebec Platelet Disorder

For some Canadians, any cut such as from dental work or surgery can cause days or more of bleeding. Although they are not hemophiliacs, for some an ordinary bruise can balloon into the size of an orange.

4 Mar 2010

'Fake pot' can cause hallucinations and seizures

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures.

4 Mar 2010

Top ten beauty treatments

RoxSpa, one of the most prestigious and luxurious medi-spas in Beverly Hills, announces their annual 'Top Ten' face and body rejuvenation treatments that are both highly-effective and provide the most satisfying results.

4 Mar 2010

DVT Awareness In Motion: Educational program on the importance of preventative care for DVT

The Coalition to Prevent Deep-Vein Thrombosis moves into action with the seventh national DVT Awareness Month by introducing DVT Awareness In Motion, a educational program designed to drive dialogue about the importance of preventative care for DVT via simple movements – that can be done anywhere and anytime.

4 Mar 2010

SpePharm Holding acquires global rights to Savene from TopoTarget

SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.

4 Mar 2010

Severe inflammatory diseases: Blocking "death messenger" might be a promising treatment

The signaling molecule CD95L, known as "death messenger," causes an inflammatory process in injured tissue after spinal cord injuries and prevents its healing. This discovery was published by scientists of the German Cancer Research Center. In mice, the researchers found out that if they switch off CD95L, the injured spinal cord heals and the animals regain better ability to move. Therefore, substances which block the death messenger might offer a new approach in the treatment of severe inflammatory diseases.

4 Mar 2010

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

University of Calgary chemistry professor David Cramb is a step closer to helping solve a complex problem in nanotechnology: the impact nanoparticles have on human health and the environment.

4 Mar 2010

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.

4 Mar 2010

Propofol is safe for endoscopic procedures with low rate of sedation-related adverse events: Study

Propofol is safe for advanced endoscopic procedures with a low rate of sedation-related adverse events when administered by a trained professional, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.

4 Mar 2010

Blood News and Research

‘Testing Millions’ World AIDS Day campaign surpasses its goal by testing more than 4.2M people for HIV

Combating liver fluke: Queen's University Belfast heads international research effort

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Gene involved in susceptibility and resistance to TB identified

St. Baldrick’s Foundation Infusion Center opened for children undergoing chemotherapy treatments

South West Liver Unit researchers receive grants for developing Hepatitis C vaccine

Risk of MS increases by many folds following infection with EBV: Study

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Proper diagnosis, treatment and good skin care help control acne and rosacea

Dermatologist addresses common parasitic infestations and latest treatment options at Academy Annual Meeting

FDA approves CSL Behring's Hizentra for PI

Scientists discover genetic cause of Quebec Platelet Disorder

'Fake pot' can cause hallucinations and seizures

Top ten beauty treatments

DVT Awareness In Motion: Educational program on the importance of preventative care for DVT

SpePharm Holding acquires global rights to Savene from TopoTarget

Severe inflammatory diseases: Blocking "death messenger" might be a promising treatment

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

Propofol is safe for endoscopic procedures with low rate of sedation-related adverse events: Study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News